Core Insights - The event in Luohu District attracted 139 enterprises, showcasing its industrial potential and commitment to strategic emerging industries [1][2] - The "Zhanxin Yue Sheng" plan was introduced, offering up to 50 million yuan in resources for flagship enterprises, emphasizing capital and spatial support [2][3] - Six key projects were signed, focusing on aerospace technology, artificial intelligence, and healthcare, aligning with Luohu's development strategy [3][4] Group 1 - The investment promotion event highlighted Luohu's industrial charm and development determination through immersive experiences and strategic planning [1][2] - The "Zhanxin Yue Sheng" plan includes a resource package with 30 million yuan in capital support, showcasing Luohu's financial commitment to new industries [2][3] - The event marked the establishment of new industrial coordinates, including the Asia-Pacific SME Cooperation Zone and the Hongmeng Ecological Gathering Area [3][4] Group 2 - Luohu has a mature industrial system, with modern service industries accounting for 74% and significant contributions to GDP and tax revenue [4][5] - The district aims to expand its industrial space by over 5 million square meters and establish a 50 billion yuan cooperation fund to attract global enterprises [5] - Luohu's focus on providing a complete ecosystem for growth, including substantial support for AI companies, enhances its attractiveness to investors [3][5]

Core Viewpoint - The investment inspection activity in Luohu District, Shenzhen, aims to showcase the district's industrial potential and attract global capital, emphasizing the theme of "Industrial Upgrade · New Momentum" [1][3]. Group 1: Investment Opportunities - The event attracted representatives from 139 enterprises, highlighting Luohu's commitment to industrial enhancement and strategic emerging industries [1]. - The B1 plot, located in the core area of the Shenzhen-Hong Kong port economic belt, is designated for a demonstration park focusing on life health, cross-border finance, and international trade, with a planned area of approximately 300,000 square meters [3][4]. - Luohu's "Zhanxin Leap" plan offers resource packages up to 50 million yuan to support enterprise development throughout their lifecycle [11][18]. Group 2: Industrial Development - Over the past five years, Luohu has seen the establishment of 1,067 new enterprises in strategic emerging industries, with a year-on-year output growth of 30.5% [7][8]. - The district's industrial structure is highly mature, with modern service industries accounting for 74% and productive service industries for 65% of the total [8]. - Luohu is developing a comprehensive industrial ecosystem, including high-end manufacturing and technology sectors, with significant projects in aerospace, AI, and health care [20][21]. Group 3: Infrastructure and Connectivity - The Qing Shui He Digital New City is positioned as a second headquarters base in Shenzhen, with future connectivity to multiple metro lines and a total property area of 107,000 square meters [4]. - The ongoing environmental restoration project in the Yulong area is expected to be completed by the end of 2026, creating a concentrated industrial area of approximately 300,000 square meters [4][8]. Group 4: Strategic Partnerships - Six enterprises signed agreements with Luohu, focusing on cutting-edge fields such as aerospace technology and AI, which align with the district's strategic industrial development [20][21]. - Luohu is actively collaborating with venture capital and industry funds to attract key projects, enhancing its position as a hub for innovation and investment [21].

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 藥師幫股份有限公司 (於開曼群島註冊成立之有限公司) 呈交日期: 2025年12月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 09885 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 20,000,000,000 | USD | 0.0000025 | USD | | 50,000 | | 增加 / 減少 (-) | | | | | | USD | | | | 本月底結存 | | | 20,000,000,000 | USD | 0.0000025 | USD | | 50,000 | ...

Core Insights - The latest shareholder equity disclosures for Baixinan-B (02185), Yaoshibang (09885), and Shiyao Group (01093) were conducted on November 25, 2025 [1] Group 1: Baixinan-B (02185) - Winning Powerful Limited increased its holdings from 45.7756 million shares to 45.7856 million shares, representing a holding percentage change from 19.42% to 19.43% [2] - Wang Philip Li also increased his holdings from 84.9577 million shares to 84.9677 million shares, with a holding percentage change from 36.04% to 36.05% [2] Group 2: Yaoshibang (09885) - Chen Fei increased his holdings from 9 million shares to 9.15 million shares, with a holding percentage change from 1.32% to 1.34% [2] Group 3: Shiyao Group (01093) - Cai Dongchen increased his holdings from 2.872 billion shares to 2.887 billion shares, with a holding percentage change from 24.93% to 25.06% [2]

Group 1 - The Hong Kong stock market experienced a phase of rebound with the Hang Seng Index closing up by 1.97% on November 24, following a decline of over 5% in the previous week due to concerns over global liquidity and debates surrounding the AI bubble [1] - From early November to the end of December, the Hong Kong stock market will face significant unlocking pressure, with an estimated unlocking scale of approximately 32.1% of the total for the year, amounting to about 197.13 billion HKD [1][2] - The unlocking of shares is primarily due to the expiration of lock-up periods for cornerstone investors of newly listed "A+H" stocks and certain new economy companies, leading to a phase of unlocking peak in the market [2] Group 2 - Notable individual stock unlockings include CATL unlocking 77.45 million shares valued at 37.4 billion HKD, and Heng Rui Pharmaceutical unlocking 93.77 million shares on November 24 [2] - The large-scale unlocking of shares is expected to exert direct pressure on stock prices and market sentiment, potentially leading to increased volatility as early investors may have selling expectations [2][3] Group 3 - Despite the emotional and financial disturbances in the Hong Kong market, incremental capital is quietly increasing, with southbound funds totaling 110.6 billion HKD inflow since November [4] - The five sectors with the largest net inflows from southbound funds include banking, oil and petrochemicals, non-bank financials, electronics, and real estate, indicating strong interest in these areas [4] Group 4 - Stock buybacks have remained high, with a total of 152.8 billion HKD in buybacks this year, as companies like Tencent and Xiaomi actively repurchase shares to stabilize the market [4][5] - The buyback activity is seen as a direct effort from companies to counter market selling pressure and enhance per-share earnings, thus increasing intrinsic stock value [5] Group 5 - Analysts predict that the unlocking tide will peak in December and then decrease to below 50 billion HKD in January, with expectations of significant inflows from southbound funds in early next year [5] - The market is anticipated to benefit from a new upward cycle led by AI, with scarce assets in the Hong Kong market likely to stand out [5]

香港联交所最新数据显示，11月24日，执行董事陈飞增持药师帮(09885)15万股，每股作价6.75港元，总 金额为101.25万港元。增持后最新持股数目为915万股，持股比例为1.34%。 ...

Group 1: Sanofi Pharmaceutical - Sanofi Pharmaceutical announced plans to spin off its subsidiary Mandi Holdings for independent listing on the Hong Kong Stock Exchange [1] - The proposed spin-off will involve a distribution of Mandi shares to existing shareholders based on their holdings in Sanofi [1] - Mandi Holdings is registered in the Cayman Islands and is currently owned by Sanofi and other entities, with Sanofi holding approximately 87.16% [1] Group 2: Yaoshi Bang - Yaoshi Bang reported a 15% year-on-year revenue growth for the third quarter ending September 30, 2025, surpassing the growth rate of the first half of 2025 compared to the same period in 2024 [2] - The company's self-owned brand business saw a transaction volume increase of over 350% year-on-year, contributing significantly to overall growth [2] - The strategic focus on self-owned brand products aims to meet diverse market demands and enhance profitability [2] Group 3: SenseTime Medical - SenseTime Medical completed a new round of strategic financing amounting to several hundred million yuan, with notable investors including Lenovo Ventures and others [3] - This financing reflects strong market recognition of SenseTime Medical's technological capabilities and growth potential [3] - The company is also initiating Series A financing with a post-investment valuation exceeding 3 billion yuan [3] Group 4: National Medical Products Administration - The National Medical Products Administration released a document outlining 24 reform measures to enhance the quality and safety of cosmetics [4] - The reforms aim to encourage innovation, optimize registration management, and strengthen risk prevention across the cosmetics industry [4] - By 2030, the goal is to have a more robust regulatory framework and improved safety standards in the cosmetics sector [4] Group 5: Hanyu Pharmaceutical - Hanyu Pharmaceutical announced the appointment of former senior executive Shen Yaping from Heng Rui Pharmaceutical as the new Executive President [5][6] - Shen Yaping has extensive experience in international business development and regulatory affairs in the pharmaceutical industry [6] - The company aims to adapt to a complex market environment through this strategic leadership change [6] Group 6: Meili Tianyuan Medical Health - Meili Tianyuan Medical Health plans to acquire 100% equity of several companies for a total consideration of 40 million yuan [7] - The acquisition will expand the company's direct-operated stores by 19, including two medical beauty stores and 17 lifestyle beauty stores [7] - This move is expected to enhance the company's revenue and strengthen its market presence in key cities in the Greater Bay Area [7]

Group 1 - The executive director Chen Fei increased his stake in Yaoshibang (09885) by purchasing 200,000 shares at a price of HKD 6.964 per share, totaling approximately HKD 1.3928 million [1] - After the purchase, the total number of shares held by Chen Fei is approximately 9 million, representing a holding percentage of 1.32% [1]

智通财经APP获悉，香港联交所最新数据显示，11月20日，执行董事陈飞增持药师帮(09885)20万股，每 股作价6.964港元，总金额约为139.28万港元。增持后最新持股数目约为900万股，持股比例为1.32%。 ...

| 荃信生物-B(02509) | 4.68 万 | 99.78 万 | 82.94 万 | 0.373% | | --- | --- | --- | --- | --- | | 联易融科技-W(09959) | 38.00 万 | 96.51 万 | 1.07 亿 | 4.997% | | 永达汽车(03669) | 50.00 万 | 79.59 万 | 1895.00 万 | 1.010% | | 方正控股(00418) | 73.40 万 | 65.05 万 | 3904.60 万 | 3.254% | | 粉笔(02469) | 20.00 万 | 63.40 万 | 666.60 万 | 0.298% | | 中远海发(02866) | 50.00 万 | 57.99 万 | 350.00 万 | 0.102% | | 威高股份(01066) | 10.00 万 | 53.36 万 | 1938.60 万 | 4.293% | | 易点云(02416) | 18.10 万 | 39.74 万 | 765.95 万 | 1.463% | | 朝聚眼科(02219) | 12.00 万 | 31.06 ...